Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/29/2025

IV Midazolam Dosing for Anxiolysis in Pediatric Patients

Dosing Guidelines

  • For anxiolysis in a pediatric patient, administer IV midazolam 0.05-0.10 mg/kg, with a maximum single dose not exceeding 5 mg, as recommended by the American Academy of Pediatrics 1, 2, 3
  • Start with 0.05 mg/kg and wait 3-5 minutes to assess peak effect before considering redosing, according to the American Academy of Pediatrics guidelines 1, 2
  • Use a "dose/observe/redose/observe" approach every 3-5 minutes to avoid oversedation, as suggested by the American Academy of Pediatrics 1, 2, 3

Critical Safety Considerations

  • Continuous pulse oximetry monitoring is mandatory when administering IV midazolam, as recommended by the American Academy of Pediatrics 1, 4
  • Be prepared to provide immediate respiratory support, as apnea can occur, and have flumazenil immediately available to reverse life-threatening respiratory depression, according to the American Academy of Pediatrics guidelines 1, 2, 3
  • The risk of respiratory depression increases significantly when midazolam is combined with opioids or other sedative agents, as noted by the American Academy of Pediatrics 1, 4

Age-Specific Context

  • The American Academy of Pediatrics guidelines support 0.05-0.10 mg/kg for sedation/anxiolysis across pediatric age groups, including patients 6-12 years old 1, 2, 3
  • Starting at the lower end (0.05 mg/kg) with careful titration is the safest approach for pediatric patients, as recommended by the American Academy of Pediatrics 1

Comparison with Alternative Routes

  • Oral midazolam (0.25-0.50 mg/kg, maximum 20 mg) could be considered for less urgent anxiolysis, but IV route allows for precise titration and is preferred when immediate anxiolysis is needed, according to the American Academy of Pediatrics guidelines 1, 2, 3